Overview of tumor cell chemoresistance mechanisms
- PMID: 15911977
- DOI: 10.1385/1-59259-889-7:127
Overview of tumor cell chemoresistance mechanisms
Abstract
Drug resistance of tumor cells is recognized as the primary cause of failure of chemotherapeutic treatment of most human tumors. Although pharmacological factors including inadequate drug concentration at the tumor site can contribute to clinical resistance, cellular factors play a major role in chemoresistance of several tumors. Although manifestations of resistance are conventionally referred to as acquired or intrinsic on the basis of the initial response to the first therapy, a common feature is the development of a phenotype resistant to a variety of structurally and functionally distinct agents. In both manifestations, drug resistance is a multifactorial phenomenon involving multiple interrelated or independent mechanisms. A heterogeneous expression of involved mechanisms may characterize tumors of the same type or cells of the same tumor and may at least in part reflect tumor progression. The relevant mechanisms that can contribute to cellular resistance include: increased expression of defense factors involved in reducing intracellular drug concentration; alterations in drug-target interaction; and changes in cellular response, in particular increased cell ability to repair DNA damage or tolerate stress conditions, and defects in apoptotic pathways. This chapter presents an overview of the drug resistance mechanisms.
Similar articles
-
Understanding cisplatin resistance using cellular models.IUBMB Life. 2007 Nov;59(11):696-9. doi: 10.1080/15216540701636287. IUBMB Life. 2007. PMID: 17885832 Review.
-
Molecular mechanisms of drug resistance.J Pathol. 2005 Jan;205(2):275-92. doi: 10.1002/path.1706. J Pathol. 2005. PMID: 15641020 Review.
-
The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications.Biochem Cell Biol. 1997;75(4):315-25. Biochem Cell Biol. 1997. PMID: 9493954 Review.
-
Apoptotic versus genotoxic potential of anti-tumor agents: a concept of duality in unity.Med Hypotheses. 2003 Nov-Dec;61(5-6):643-50. Med Hypotheses. 2003. PMID: 14592801
-
[Research advance on role of tumor microenvironment in mediating acquired drug resistance].Ai Zheng. 2007 Aug;26(8):923-6. Ai Zheng. 2007. PMID: 17697561 Review. Chinese.
Cited by
-
The E3 ubiquitin ligase NEDD4 regulates chemoresistance to 5-fluorouracil in colorectal cancer cells by altering JNK signalling.Cell Death Dis. 2023 Dec 14;14(12):828. doi: 10.1038/s41419-023-06349-z. Cell Death Dis. 2023. PMID: 38097550 Free PMC article.
-
Studies on anticancer activities of antimicrobial peptides.Biochim Biophys Acta. 2008 Feb;1778(2):357-75. doi: 10.1016/j.bbamem.2007.11.008. Epub 2007 Nov 22. Biochim Biophys Acta. 2008. PMID: 18078805 Free PMC article. Review.
-
Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer.BMC Cancer. 2013 Nov 16;13:549. doi: 10.1186/1471-2407-13-549. BMC Cancer. 2013. PMID: 24237932 Free PMC article.
-
Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.Anticancer Agents Med Chem. 2008 May;8(4):358-67. doi: 10.2174/187152008784220311. Anticancer Agents Med Chem. 2008. PMID: 18473721 Free PMC article. Review.
-
Effects of Andrographolide on Intracellular pH Regulation, Cellular Migration, and Apoptosis in Human Cervical Cancer Cells †.Cancers (Basel). 2020 Feb 7;12(2):387. doi: 10.3390/cancers12020387. Cancers (Basel). 2020. PMID: 32046125 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources